Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

Mass. Gov. Patrick Signs Legislation Allocating $1B For Biotechnology Research

Main Category: Pharma Industry / Biotech Industry
Also Included In: Stem Cell Research
Article Date: 19 Jun 2008 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Massachusetts Gov. Deval Patrick (D) on Monday signed a measure that will allocate $1 billion to the biotechnology industry over 10 years, the Boston Globe reports (Boston Globe, 6/16). The measure includes $250 million in tax incentives for biotech companies; $250 million in grants for research, fellowships and work force training; and $500 million for infrastructure, including a stem cell bank at the University of Massachusetts Medical School.

According to Reuters, the bill aims to fill a funding shortfall caused by a ban on the use of federal funds for human embryonic stem cell research, as well as to challenge California's "dominance" in the field (Szep, Reuters, 6/16). Federal funding for embryonic stem cell research is allowed only for research using embryonic stem cell lines created on or before Aug. 9, 2001, under a policy announced by President Bush on that date (Daily Women's Health Policy Report, 4/10). California voters in 2004 approved a plan to invest $3 billion of tax funds over 10 years into embryonic stem cell research (Daily Women's Health Policy Report, 5/9).

Patrick said the measure will help researchers develop cures for diseases and create new jobs in the state. "This initiative is about so much more than putting researchers and resources together," Patrick said adding that it is "about Massachusetts advancing human healing." Rep. Mary Rogeness (R), who voted against the measure, said she is opposed to it because it gave tax breaks to biotech companies but not other companies (Ring, Springfield Republican, 6/17).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
24 Jun 2009
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe...


Menopause - The Ups and Downs of Change
Menopause - The Ups and Downs of Change

Menopause brings with it physical and emotional changes. But there are advantages to this time of life.

more videos are available in our health videos section.